Rite Aid Fundamentals

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>RA</div>
RAD -- USA Stock  

 Earnings Call  In Two Weeks

Rite Aid fundamental analysis lookup allows you to check this and other indicators for Rite Aid or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please continue to Equity Screeners to view more equity screening tools

Search Fundamentals

 
Refresh
Rite Aid Consolidated Income is expected to significantly increase based on the last few years of reporting. The last year's Consolidated Income was at 1.9 Billion. The current year Earning Before Interest and Taxes EBIT is expected to grow to about 800.6 M, whereas Gross Profit is expected to decline to about 4.7 B.

Rite Aid EBITDA Analysis

EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
 2014 2016 2019 2020 (projected)
Interest Expense449.57 M397.61 M357.85 M363.38 M
Gross Profit7.83 B7.58 B6.82 B4.68 B
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. Rite Aid Corporation was founded in 1962 and is headquartered in Camp Hill, Pennsylvania. Rite Aid operates under Pharmaceutical Retailers classification in USA and is traded on BATS Exchange. It employs 29840 people.
EBITDA 
 = 
Revenue 
-  
Basic Expenses 
More About EBITDA | All Equity Analysis

Current Rite Aid EBITDA

905.39 M

Rite Aid EBITDA Over Time Pattern

 Rite Aid Earnings Before Interest Taxes and Depreciation Amortization EBITDA 
      Timeline 

About EBITDA

In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Compare to competition

Rite Aid EBITDA Related Assessment

  EBITDA Margin

According to company disclosure Rite Aid reported earnings before interest,tax, depreciation and amortization of 905.39 M. This is 3.19% higher than that of the Healthcare sector, and significantly higher than that of Pharmaceutical Retailers industry, The EBITDA for all stocks is 76.78% higher than the company.

Rite Aid Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Rite Aid's current stock value. Our valuation model uses many indicators to compare Rite Aid value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Rite Aid competition to find correlations between indicators driving Rite Aid's intrinsic value. More Info.
Rite Aid is rated below average in debt to equity category among related companies. It is rated below average in price to earnings to growth category among related companies producing about  0.01  of Price to Earnings To Growth per Debt to Equity. The ratio of Debt to Equity to Price to Earnings To Growth for Rite Aid is roughly  139.25 . Rite Aid Earnings before Tax are expected to significantly increase based on the last few years of reporting. The last year's Earnings before Tax were at 384.14 Million

Did you try this?

Run Transaction History Now

   

Transaction History

View history of all your transactions and understand their impact on performance
All  Next Launch Module

Rite Aid Fundamentals

About Rite Aid Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Rite Aid's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rite Aid using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rite Aid based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way. Please read more on our fundamental analysis page.
 2010 2014 2019 2020 (projected)
Receivables949.06 M1.79 B1.29 B1.22 B
Inventories2.99 B1.87 B1.92 B2.57 B
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. Rite Aid Corporation was founded in 1962 and is headquartered in Camp Hill, Pennsylvania. Rite Aid operates under Pharmaceutical Retailers classification in USA and is traded on BATS Exchange. It employs 29840 people.


 
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page